UNSPSC 51242305: Dioxybenzone/ethyl dihydroxypropyl paba/hydroquinone

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class DE300. This VA Drug Class (DE300) classifies this compound as belonging to the group SUN PROTECTANTS/SCREENS, TOPICAL.

UNSPSC 51242305 Dioxybenzone/ethyl dihydroxypropyl paba/hydroquinone (Commodity) shows minimal alignment between its nominal scope and recent state and local procurement activity. The code's chemical constituents—sunscreen and skin-lightening agents—do not match the opportunities posted under this classification. The City of Austin's IFB for liquid aluminum sulfate (alum) for wastewater treatment phosphorus removal and the City of Tampa Fire Rescue's ITB for medical aid supplies (bandages, antiseptic sprays, hydrogen peroxide, pain relievers, first aid kits, and emergency blankets) represent the recent activity tagged to this code, yet neither involves the dermatological or sunscreen formulations the code nominally describes. The mismatch suggests either a tagging error in the source data or a jurisdiction-specific coding practice that diverges from the UNSPSC taxonomy's standard intent.

Recent opportunities under this code come from municipal water utilities and fire departments in Texas and Florida. The City of Austin's IFB 2200 CSH1061, due August 25, 2026, seeks 179,200 gallons annually of NSF-approved unpackaged liquid aluminum sulfate at 47%-49% concentration, with local and small business preference discounts of 3–5% available on bids up to $50 million and firm pricing locked for 12 months. The City of Tampa Fire Rescue's ITB 25-P-00157, posted April 24, 2026, targets 32 medical supply line items with an estimated annual budget of $100,000, set-asides for City-certified small local businesses and underutilized women- and minority-owned enterprises offering discounts up to $20,000, and contract renewals available through a three-year term. The code shows little relevant activity outside these two solicitations and does not support a business development strategy focused on the dermatological formulations the code nominally describes.